2007-02-12T00:00:00
In recent months, the media has reported numerous cases of patients campaigning to be given expensive anti-cancer drugs such as Herceptin by the NHS despite a lack of NICE approval. Difficult decisions must be made about how money should be spent and where economies can be made.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud